logo-loader
Energy
Parkmead Group

This oiler has 50% upside, but what's driving the shares today?

Parkmead has increased proved and probable reserves to 27.9mln barrels of oil equivalent from 23.5mln.

15740530049_fbf60740a4_o.jpg
The company wants to create a hub operation around what's currently one of the largest undeveloped areas in the North Sea.

Shares in Parkmead Group PLC (LON:PMG) rose 14% after clinching a deal that will increase its oil reserves in the Moray Firth by almost a fifth.

It now owns just over 60% (up from 52%) of the licences for the Perth and Dolphin (PDL) areas that are host to two “sizeable” accumulations light crude and that have been tested at production rates of 6,000 barrels a day.

As a result of the transaction, Parkmead has increased proved and probable reserves to 27.9mln barrels of oil equivalent from 23.5mln.

No financial details were given.

This latest deal follows the company’s recent acquisition of an additional 50% of the Polecat and Marten fields, announced last month.

Given their proximity to Perth and Dolphin, it is hoped they can be incorporated into a larger North Sea oil producing area.

The Moray Firth is already host to some big operations, including the Piper, Claymore and Tartan fields.

“This growth step strengthens Parkmead's asset base in the centre of the company's major Perth-Dolphin-Lowlander oil hub project, which is one of the largest undeveloped oil projects in the North Sea,” said Parkmead chief executive Tom Cross.

Shares in Parkmead, which have advanced 30% in the year to date, were changing hands for 55.94p for a rise of 6.69p.

The small-cap broker finnCap reckons the stock is worth 80p, while Panmure Gordon says 'buy' up to 105p.

"The pace of deal activity at Parkmead is picking up, and we continue to anticipate that the company will be able to achieve further value adding deals, given Tom Cross’s track record and what looks like a market for transactions in the UK North Sea that is beginning to creak open," said Panmure's Colin Smith.

 

 

 

Quick facts: Parkmead Group

Price: £0.40

Market: AIM
Market Cap: £39.87 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

21 hours, 44 minutes ago

2 min read